8-17274828-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152415.3(VPS37A):c.512C>T(p.Thr171Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T171S) has been classified as Uncertain significance.
Frequency
Consequence
NM_152415.3 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 53Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VPS37A | NM_152415.3 | c.512C>T | p.Thr171Ile | missense_variant | Exon 5 of 12 | ENST00000324849.9 | NP_689628.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| VPS37A | ENST00000324849.9 | c.512C>T | p.Thr171Ile | missense_variant | Exon 5 of 12 | 1 | NM_152415.3 | ENSP00000318629.4 | ||
| VPS37A | ENST00000521829.5 | c.437C>T | p.Thr146Ile | missense_variant | Exon 4 of 11 | 1 | ENSP00000429680.1 | |||
| VPS37A | ENST00000425020.6 | n.540C>T | non_coding_transcript_exon_variant | Exon 6 of 12 | 2 | ENSP00000412824.2 | ||||
| VPS37A | ENST00000520140.5 | n.512C>T | non_coding_transcript_exon_variant | Exon 5 of 12 | 5 | ENSP00000428823.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152170Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251442 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461862Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 727228 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74326 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 53 Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 171 of the VPS37A protein (p.Thr171Ile). This variant is present in population databases (rs200401367, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with VPS37A-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt VPS37A protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at